B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Recall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

BHUBANESWAR: Ananta Mahakud had always envisioned a bright future for his only daughter Truptimayee. His dreams came crashing ...

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

A 57-year-old woman with a 12-h history of fever and severe pain in her back, pelvis, and thighs attended our hospital. 24 h ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment ...

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease and has raised £63.5 million ...

Here’s a round-up of crime news from across B.C. on Oct. 3, 2024. Package containing meth, cell phones seized at Matsqui ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

The Liberal and Green Parties both tackled improving cell service in announcements Tuesday, but for different reasons. Meanwhile, the Progressive Conservatives threatened to sue the federal government ...